An exercise-inducible metabolite that suppresses feeding and obesity

  • Veronica L. Li
  • , Yang He
  • , Kévin Contrepois
  • , Hailan Liu
  • , Joon T. Kim
  • , Amanda L. Wiggenhorn
  • , Julia T. Tanzo
  • , Alan Sheng Hwa Tung
  • , Xuchao Lyu
  • , Peter James H. Zushin
  • , Robert S. Jansen
  • , Basil Michael
  • , Kang Yong Loh
  • , Andrew C. Yang
  • , Christian S. Carl
  • , Christian T. Voldstedlund
  • , Wei Wei
  • , Stephanie M. Terrell
  • , Benjamin C. Moeller
  • , Rick M. Arthur
  • Gareth A. Wallis, Koen van de Wetering, Andreas Stahl, Bente Kiens, Erik A. Richter, Steven M. Banik, Michael P. Snyder, Yong Xu*, Jonathan Z. Long*
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
208 Downloads (Pure)

Abstract

Exercise confers protection against obesity, type 2 diabetes and other cardiometabolic diseases1–5. However, the molecular and cellular mechanisms that mediate the metabolic benefits of physical activity remain unclear6. Here we show that exercise stimulates the production of N-lactoyl-phenylalanine (Lac-Phe), a blood-borne signalling metabolite that suppresses feeding and obesity. The biosynthesis of Lac-Phe from lactate and phenylalanine occurs in CNDP2+ cells, including macrophages, monocytes and other immune and epithelial cells localized to diverse organs. In diet-induced obese mice, pharmacological-mediated increases in Lac-Phe reduces food intake without affecting movement or energy expenditure. Chronic administration of Lac-Phe decreases adiposity and body weight and improves glucose homeostasis. Conversely, genetic ablation of Lac-Phe biosynthesis in mice increases food intake and obesity following exercise training. Last, large activity-inducible increases in circulating Lac-Phe are also observed in humans and racehorses, establishing this metabolite as a molecular effector associated with physical activity across multiple activity modalities and mammalian species. These data define a conserved exercise-inducible metabolite that controls food intake and influences systemic energy balance.

Original languageEnglish
Pages (from-to)785-790
Number of pages6
JournalNature
Volume606
Issue number7915
Early online date15 Jun 2022
DOIs
Publication statusPublished - 23 Jun 2022

Bibliographical note

Funding Information:
We thank members of the Long, Xu, Snyder, Richter and Svensson laboratories, and L. Sylow for helpful discussions. This work was supported by the NIH (DK124265 and DK130541 to J.Z.L.; DK113954, DK115761, DK117281 and DK120858 to Y.X.; GM113854 to V.L.L.; and AR072695 to K.v.d.W), the Ono Pharma Foundation (research grant to J.Z.L.), BASF (research grant to J.Z.L.), the USDA (51000-064-01S to Y.X.), the American Heart Association (20POST35120600 to Y.H.), the Novo Nordisk Foundation (NNF17OC0027274 and NNF18OC00334072 to E.A.R.) and PXE International (research grant to K.v.d.W.).

Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature Limited.

Keywords

  • Adiposity/drug effects
  • Animals
  • Body Weight/drug effects
  • Diabetes Mellitus, Type 2
  • Disease Models, Animal
  • Eating/physiology
  • Energy Metabolism
  • Feeding Behavior/physiology
  • Glucose/metabolism
  • Lactic Acid/metabolism
  • Mice
  • Obesity/metabolism
  • Phenylalanine/administration & dosage
  • Physical Conditioning, Animal/physiology

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'An exercise-inducible metabolite that suppresses feeding and obesity'. Together they form a unique fingerprint.

Cite this